ENNUMO Trademark

Trademark Overview


On Wednesday, May 6, 2026, a trademark application was filed for ENNUMO with the United States Patent and Trademark Office. The USPTO has given the ENNUMO trademark a serial number of 99806284. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 6, 2026. This trademark is owned by Accord Biopharma, Inc.. The ENNUMO trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of of cancer and cancer-related comorbidities; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for stimulating white blood cell production; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of of cancer and cancer-related comorbidities
ennumo

General Information


Serial Number99806284
Word MarkENNUMO
Filing DateWednesday, May 6, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, May 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of The mark consists of a positive-space hexagon with a hexagonshapednegative space in the center where the positive-spacehexagon is divided in half by the negative-space hexagon andtwo negative-space lines, one negative-space line radiating in adownward curve to the left from the upper left corner of thenegative-space hexagon to the outside of the middle left cornerof the positive-space hexagon, and one negative-space lineradiating in an upward curve to the right from the lower rightcorner of the negative-space hexagon to the outside of themiddle right corner of the positive-space hexagon. The upperhalf of the positive-space hexagon is orange and the bottomhalf of the positive-space hexagon is teal. To the right of thehexagon is the word "ENNUMO" in orange stylized font.
Goods and ServicesTherapeutic pharmaceutical for the treatment of of cancer and cancer-related comorbidities; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for stimulating white blood cell production; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of of cancer and cancer-related comorbidities
Indication of Colors claimedThe color(s) orange and teal is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAccord Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617
US

Trademark Events


Event DateEvent Description
Wednesday, May 6, 2026NEW APPLICATION ENTERED
Wednesday, May 6, 2026APPLICATION FILING RECEIPT MAILED